Bessemer Group Inc. Has $123.59 Million Holdings in Agilent Technologies, Inc. $A

Bessemer Group Inc. boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 908,257 shares of the medical research company’s stock after buying an additional 23,085 shares during the period. Bessemer Group Inc. owned about 0.32% of Agilent Technologies worth $123,587,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Board of the Pension Protection Fund acquired a new stake in Agilent Technologies during the 4th quarter worth about $27,000. Navalign LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $27,000. Physician Wealth Advisors Inc. raised its holdings in Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after buying an additional 196 shares during the period. Torren Management LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $32,000. Finally, State of Wyoming acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at about $35,000.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on A. TD Cowen decreased their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. HSBC began coverage on Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price for the company. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Barclays decreased their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $163.71.

Agilent Technologies Stock Down 1.4%

A opened at $111.69 on Friday. Agilent Technologies, Inc. has a 1-year low of $107.07 and a 1-year high of $160.27. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $31.56 billion, a price-to-earnings ratio of 24.66, a P/E/G ratio of 2.38 and a beta of 1.22. The business has a 50 day moving average of $115.06 and a 200-day moving average of $130.68.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the prior year, the company posted $1.31 earnings per share. The firm’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.